Recent News Eli Lilly Bolsters Genetic Medicine Portfolio Through Strategic Acquisition of Orna Therapeutics Eli Lilly and Company has announced a definitive agreement to acquire Orna Therapeutics in a transaction valued at approximately 2.4 billion dollars, by Josh Weiner 1 month ago